Giselli Scaini1
, Samira S. Valvassori2, Alexandre P. Diaz1,3, Camila N. Lima1, Deborah Benevenuto1, Gabriel R. Fries1,4,5
, Joao Quevedo1,2,3,5
DOI: 10.1590/1516-4446-2019-0732
Epub: 3 de Abril de 2020
1Translational Psychiatry Program Louis A. Faillace, Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
2Laboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
3Center of Excellence on Mood Disorders Louis A. Faillace, Department of Psychiatry and Behavioral Sciences at McGovern Medical School, UTHealth, Houston, TX, USA
4Center for Precision Health, School of Biomedical Informatics, UTHealth, Houston, TX, USA
5Neuroscience Graduate Program, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, UTHealth, Houston, TX, USA
João Luciano de Quevedo, The University of Texas Health Science Center at Houston, McGovern Medical School, Faillace Department of Psychiatry and Behavioral Sciences, 1941 East Road, Ste. 3216, Houston, TX 77054, USA. E-mail: Joao.L.DeQuevedo@uth.tmc.edu